Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 399

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 399
---
ivables was € 650million as of December 31, 2024 , versus € 689million as of December 31, 2023

and € 452million as of December 31, 2022 .

| (€ million)       
 December 31, 2024 
 December 31, 2023 | Overdue accountsgross value 
                         650 
                         689 | Overdue by<1 month 
                316 
                269 | Overdue by1 to 3 months 
                     194 
                     154 | Overdue by3 to 6 months 
                      87 
                     123 | Overdue by6 to 12 months 
                        9 
                       62 | Overdue by> 12 months 
                    44 
                    81 |
|:------------------|----------------------------:|-------------------:|------------------------:|------------------------:|-------------------------:|----------------------:|
| December 31, 2022 |                         452 |                118 |                     161 |                      87 |                       35 |                    51 |

Amounts overdue by more than one month relate mainly to public-sector customers.

Some Sanofi subsidiaries have assigned receivables to factoring companies or banks without recourse . The amount of

receivables derecognized was € 14million as of December 31, 2024 ( € 761million as of December 31, 2023 and € 131million as

of December 31, 2022 ). The residual guarantees relating to such transfers were immaterial as of December 31, 2024 .

D.11. Other current assets

An analysis of Other current assets is set forth below:

| (€ million)                                                  |  2024 |  2023 |  2022 |
| Tax receivables, other than corporate income taxes           |   782 |   768 |   660 |
| Prepaid expenses                                             |   895 |   768 |   714 |
| Other receivables(a)                                         | 1,446 | 1,448 | 1,289 |
| Currency derivatives measured at fair value (see Note D.20.) |   217 |   201 |   206 |
| Other financial assets at fair value through profit or loss  |   115 |   112 |   146 |
| Other current financial assets(b)                            |   371 |   158 |